DIRECT CHARACTERIZATION OF THE SELECTIVITY OF FURAFYLLINE AS AN INHIBITOR OF HUMAN CYTOCHROMES P450 1A1 AND 1A2

被引:42
作者
TASSANEEYAKUL, W
BIRKETT, DJ
VERONESE, ME
MCMANUS, ME
TUKEY, RH
MINERS, JO
机构
[1] FLINDERS UNIV S AUSTRALIA,MED CTR,DEPT CLIN PHARMACOL,BEDFORD PK,SA 5042,AUSTRALIA
[2] UNIV QUEENSLAND,DEPT PHYSIOL & PHARMACOL,BRISBANE,QLD 4072,AUSTRALIA
[3] UNIV CALIF SAN DIEGO,CTR CANC,LA JOLLA,CA 92093
来源
PHARMACOGENETICS | 1994年 / 4卷 / 05期
关键词
D O I
10.1097/00008571-199410000-00007
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
[No abstract available]
引用
收藏
页码:281 / 284
页数:4
相关论文
共 12 条
[1]  
BOOBIS AR, 1994, CANCER RES, V54, P89
[2]   DETERMINATION OF CYP1A2 AND NAT2 PHENOTYPES IN HUMAN-POPULATIONS BY ANALYSIS OF CAFFEINE URINARY METABOLITES [J].
BUTLER, MA ;
LANG, NP ;
YOUNG, JF ;
CAPORASO, NE ;
VINEIS, P ;
HAYES, RB ;
TEITEL, CH ;
MASSENGILL, JP ;
LAWSEN, MF ;
KADLUBAR, FF .
PHARMACOGENETICS, 1992, 2 (03) :116-127
[3]   OXIDATION OF TOXIC AND CARCINOGENIC CHEMICALS BY HUMAN CYTOCHROME-P-450 ENZYMES [J].
GUENGERICH, FP ;
SHIMADA, T .
CHEMICAL RESEARCH IN TOXICOLOGY, 1991, 4 (04) :391-407
[4]  
KITZ R, 1962, J BIOL CHEM, V237, P3245
[5]   ISOFORM-SELECTIVE MECHANISM-BASED INHIBITION OF HUMAN CYTOCHROME-P450 1A2 BY FURAFYLLINE [J].
KUNZE, KL ;
TRAGER, WF .
CHEMICAL RESEARCH IN TOXICOLOGY, 1993, 6 (05) :649-656
[6]   LOCALIZATION OF CYP1A1 AND CYP1A2 MESSENGER-RNA IN NORMAL HUMAN LIVER AND IN HEPATOCELLULAR-CARCINOMA BY INSITU HYBRIDIZATION [J].
MCKINNON, RA ;
HALL, PD ;
QUATTROCHI, LC ;
TUKEY, RH ;
MCMANUS, ME .
HEPATOLOGY, 1991, 14 (05) :848-856
[7]  
MCMANUS ME, 1990, CANCER RES, V50, P3367
[8]  
PETERSEN DD, 1991, AM J HUM GENET, V48, P720
[9]   FURAFYLLINE IS A POTENT AND SELECTIVE INHIBITOR OF CYTOCHROME-P450IA2 IN MAN [J].
SESARDIC, D ;
BOOBIS, AR ;
MURRAY, BP ;
MURRAY, S ;
SEGURA, J ;
DELATORRE, R ;
DAVIES, DS .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 29 (06) :651-663
[10]   ACCUMULATION OF CAFFEINE IN HEALTHY-VOLUNTEERS TREATED WITH FURAFYLLINE [J].
TARRUS, E ;
CAMI, J ;
ROBERTS, DJ ;
SPICKETT, RGW ;
CELDRAN, E ;
SEGURA, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 23 (01) :9-18